Related Experiment Videos
Ras p21 expression in nephroblastoma group tumors
1Department of Pathology, Yokohama City University School of Medicine, Japan.
Acta Pathologica Japonica
|December 1, 1987
Summary
Ras p21 expression was studied in nephroblastoma and related tumors. Positive staining was observed in primitive tumor structures and rhabdomyocytic cells, but not in differentiated or congenital mesoblastic nephroma cells.
Area of Science:
- Oncology
- Molecular Biology
- Pathology
Background:
- Ras p21 is a protein involved in cell signaling and proliferation.
- Aberrant Ras p21 expression is implicated in various cancers.
- Nephroblastoma (Wilms tumor) is a common pediatric kidney cancer.
Purpose of the Study:
- To investigate the expression patterns of Ras p21 protein in nephroblastoma and related pediatric kidney tumors.
- To determine if Ras p21 expression can serve as a marker for specific tumor types or differentiation states.
Main Methods:
- Immunoperoxidase staining was performed on 30 cases of nephroblastoma and related tumors.
- A monoclonal anti-ras p21 antibody (RAP-5) was used for detection.
- Normal renal tissue was included as a control.
Main Results:
- Ras p21 was detected in normal renal tubular and arterial smooth muscle cells.
- Positive Ras p21 staining was found in epithelial cells of primitive tubular/glomerular-like structures and in rhabdomyocytic cells within nephroblastomas.
- Differentiated epithelial cells, rhabdoid cells, congenital mesoblastic nephroma cells, and non-neoplastic stromal/sarcomatous cells showed negative staining for Ras p21.
Conclusions:
- Ras p21 expression is heterogeneous in nephroblastoma and related tumors.
- Ras p21 positivity may be associated with primitive cellular components and rhabdomyocytic differentiation in nephroblastoma.
- Ras p21 does not appear to be a universal marker for all types of pediatric kidney tumors, particularly differentiated or congenital mesoblastic nephroma.